Cannabis Watch: U.S. FDA weighs regulations on cannabis products in food and diet supplements

FDA officials tell the Wall Street Journal that safety concerns around CBD may cause the agency to publish its first guidelines on cannabis-derived products.

Previous post Crypto: Crypto regulation: 2 big questions loom in 2023 after a chaotic year for digital assets
Next post Metals Stocks: Gold prices rally to highest intraday levels since June as U.S. dollar weakens